These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7192096

  • 21. Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. application.
    Bhargava AS, Wendt H, Günzel P.
    Arzneimittelforschung; 1981; 31(2):386-8. PubMed ID: 7194658
    [Abstract] [Full Text] [Related]

  • 22. Nonspecific electrostatic binding characteristics of the heparin-antithrombin interaction.
    Seyrek E, Dubin PL, Henriksen J.
    Biopolymers; 2007 Jun 15; 86(3):249-59. PubMed ID: 17385667
    [Abstract] [Full Text] [Related]

  • 23. Heparin-sepharose affinity chromatography of human post-heparin plasma. Characterization of the elution pattern with immunoelectrophoretic methods.
    Thim L.
    Scand J Clin Lab Invest; 1978 Feb 15; 38(1):77-81. PubMed ID: 75564
    [Abstract] [Full Text] [Related]

  • 24. Immobilization of high-affinity heparin oligosaccharides to radiofrequency plasma-modified polyethylene.
    Yuan S, Szakalas-Gratzl G, Ziats NP, Jacobsen DW, Kottke-Marchant K, Marchant RE.
    J Biomed Mater Res; 1993 Jun 15; 27(6):811-9. PubMed ID: 8408111
    [Abstract] [Full Text] [Related]

  • 25. Anticoagulant activity of heparin: isolation of antithrombin-binding sites.
    Hopwood J, Höök M, Linker A, Lindahl U.
    FEBS Lett; 1976 Oct 15; 69(1):51-4. PubMed ID: 992045
    [No Abstract] [Full Text] [Related]

  • 26. New antithrombin-based anticoagulants.
    Desai UR.
    Med Res Rev; 2004 Mar 15; 24(2):151-81. PubMed ID: 14705167
    [Abstract] [Full Text] [Related]

  • 27. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
    Zhao Y, Zhao R, Shangguan D, Xiong S, Liu G.
    Biomed Chromatogr; 2001 Dec 15; 15(8):487-92. PubMed ID: 11748680
    [Abstract] [Full Text] [Related]

  • 28. [Evaluation of crude heparin and commercial preparation of Polish production].
    Jarzebiński J, Tońska S, Remiszewska H.
    Acta Pol Pharm; 1989 Dec 15; 46(2):179-82. PubMed ID: 2561044
    [Abstract] [Full Text] [Related]

  • 29. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
    Uchiyama H, Fujimoto N, Sakurai K, Nagasawa K.
    J Chromatogr; 1984 Mar 30; 287(1):55-66. PubMed ID: 6725457
    [Abstract] [Full Text] [Related]

  • 30. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O, Kristensen HI, Valentin S, Ostergaard P, Wadt J.
    Thromb Haemost; 1993 Sep 01; 70(3):448-53. PubMed ID: 8259547
    [Abstract] [Full Text] [Related]

  • 31. Distribution of glucuronic and iduronic acid units in heparin chains.
    Radoff S, Danishefsky I.
    J Biol Chem; 1985 Dec 05; 260(28):15106-11. PubMed ID: 4066664
    [Abstract] [Full Text] [Related]

  • 32. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V, Béguin S, Boneu B, Hemker HC.
    Thromb Haemost; 1997 Feb 05; 77(2):312-6. PubMed ID: 9157588
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The interaction of heparin with plasma proteins. Demonstration of different binding sites for antithrombin III complexes and antithrombin III.
    McKay EJ, Laurell CB.
    J Lab Clin Med; 1980 Jan 05; 95(1):69-80. PubMed ID: 7350242
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Activation by heparin-Sepharose of prothrombin conversion to prethrombin 1].
    Strukova SM, Mitroshina TN, Kudriashov BA.
    Biokhimiia; 1981 May 05; 46(5):904-10. PubMed ID: 7295815
    [Abstract] [Full Text] [Related]

  • 38. Heparin with two binding sites for antithrombin or platelet factor 4.
    Jordan RE, Favreau LV, Braswell EH, Rosenberg RD.
    J Biol Chem; 1982 Jan 10; 257(1):400-6. PubMed ID: 7053378
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparative studies on the structures of highly active and relatively inactive forms of whale heparin.
    Ototani N, Kikuchi M, Yosizawa Z.
    J Biochem; 1981 Jul 10; 90(1):241-6. PubMed ID: 7287679
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.